Remdesivir & Favilavir trials underway


A number of drugs are in various phases of trials to combat patients with Covid-19 infections. There are two drugs that look promising subject to further testing, trials, and FDA approvals in the USA.

Remdesivir is a drug that was tried on the ebola virus with no proven success. The drug is a compound to fight different types of corono viruses. There are several trials of this drug currently underway with some promising results. However, its true effectiveness is still being evaluated pending all the trials. Patients in Washington, California, Nebraska have shown positive effects of the drugs. China is also using the drug on a trial basis. We hope, that the results are favorable so that patients that are having severe effects could have an alternative treatment. We encourage viewers to share their input on this drug or of they have experienced the usage of this drug as part of a trial.

The second drug is manufactured by China with the common name”Favilavir” or “Avigan” in Japan. This is an anti-viral drug which has received positive results on trials with Covid-19 patients in China. The drug has now been officially approved by China as part of treatment for this disease. However, FDA has not approved this drug for usage in the United States.

In addition to the two drugs mentioned, there are numerous other efforts currently underway in various stages of development. The list provided here is a sample of selected companies that are currently involved in treatments or some form of vaccination.

1. BXT-25 by BIOXYTRAN to treat late-stage acute respiratory distress syndrome (ARDS)
2. Actemra by Roche to treat coronavirus-related complications
3. Biocryst Pharma’s Galidesivir, a potential antiviral for coronavirus treatment
4. Regeneron’s REGN3048-3051 and Kevzara
5. SNG001 by Synairgen Research
6. AmnioBoost by Lattice Biologics
7. CEL-SCI
CEL-SCI is developing immunotherapy against COVID-19
8. Takeda Pharmaceutical Company
Takeda Pharmaceutical Company has announced plans to develop a plasma-derived therapy against Coronavirus.
Source: Pharmaceutical Technology. Please review their website for more details on the above vaccines and latest news. Information provided here is strictly for public information.

Collaborative Efforts
The newly formed QBI Coronavirus Research Group is an example of how bio scientists from around the world are working together to develop solutions and treatments for Covid-19. Twenty-two leading laboratories have joined forces to fight Covid-19. For more information please review the QBI website.

You May Also Like

About the Author: Syed Aman- TexasCovid19

Leave a Reply

Your email address will not be published. Required fields are marked *

The maximum upload file size: 10 MB. You can upload: image, audio, video, document, spreadsheet, interactive, other. Links to YouTube, Facebook, Twitter and other services inserted in the comment text will be automatically embedded.